| Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil EL Gouveia, J Metcalfe, ALF De Carvalho, TSF Aires, ... Emerging infectious diseases 14 (3), 505, 2008 | 316 | 2008 |
| Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma ZZ Yang, HJ Kim, JC Villasboas, YP Chen, T Price-Troska, S Jalali, ... Oncotarget 8 (37), 61425, 2017 | 174 | 2017 |
| The use of pembrolizumab for the treatment of metastatic uveal melanoma LA Kottschade, RR McWilliams, SN Markovic, MS Block, JV Bisneto, ... Melanoma research 26 (3), 300-303, 2016 | 106 | 2016 |
| The use of pembrolizumab for the treatment of metastatic uveal melanoma LA Kottschade, RR McWilliams, SN Markovic, MS Block, JV Bisneto, ... Melanoma research 26 (3), 300-303, 2016 | 106 | 2016 |
| ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L) 1 inhibitor resistance JJ Orme, KA Jazieh, T Xie, S Harrington, X Liu, M Ball, B Madden, ... Oncoimmunology 9 (1), 1744980, 2020 | 87 | 2020 |
| Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma S Jalali, T Price-Troska, C Bothun, J Villasboas, HJ Kim, ZZ Yang, ... Blood cancer journal 9 (3), 22, 2019 | 75 | 2019 |
| Clinical presentation and diagnostic challenges of thyroid lymphoma: a cohort study A Sharma, S Jasim, CC Reading, KM Ristow, JC Villasboas Bisneto, ... Thyroid 26 (8), 1061-1067, 2016 | 70 | 2016 |
| Mass cytometry analysis reveals that specific intratumoral CD4+ T cell subsets correlate with patient survival in follicular lymphoma ZZ Yang, HJ Kim, JC Villasboas, T Price-Troska, S Jalali, H Wu, ... Cell reports 26 (8), 2178-2193. e3, 2019 | 68 | 2019 |
| Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective JC Villasboas, SM Ansell, TE Witzig Oncotarget 7 (11), 13260, 2016 | 61 | 2016 |
| Multi‐site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar … CB Bagwell, B Hunsberger, B Hill, D Herbert, C Bray, T Selvanantham, ... Cytometry Part B: Clinical Cytometry 98 (2), 146-160, 2020 | 48 | 2020 |
| SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma YP Chen, HJ Kim, H Wu, T Price-Troska, JC Villasboas, S Jalali, ... Blood cancer journal 9 (10), 84, 2019 | 46 | 2019 |
| Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia S Jalali, T Price-Troska, J Paludo, J Villasboas, HJ Kim, ZZ Yang, ... Blood advances 2 (15), 1985-1997, 2018 | 45 | 2018 |
| Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia S Zanwar, JP Abeykoon, E Durot, R King, GE Perez Burbano, S Kumar, ... American journal of hematology 95 (3), 274-281, 2020 | 41 | 2020 |
| Lack of intrafollicular memory CD4+ T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma P Mondello, A Fama, MC Larson, AL Feldman, JC Villasboas, ZZ Yang, ... Blood cancer journal 11 (7), 130, 2021 | 35 | 2021 |
| Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies TV Kourelis, JC Villasboas, E Jessen, S Dasari, A Dispenzieri, ... Blood cancer journal 9 (9), 72, 2019 | 32 | 2019 |
| Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma J Cook, KW Peng, TE Witzig, SM Broski, JC Villasboas, J Paludo, ... Blood Advances 6 (11), 3268-3279, 2022 | 30 | 2022 |
| Checkpoint inhibition: programmed cell death 1 and programmed cell death 1 ligand inhibitors in Hodgkin lymphoma JC Villasboas, S Ansell The Cancer Journal 22 (1), 17-22, 2016 | 27 | 2016 |
| The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non‐follicular indolent B‐cell lymphomas SI Tracy, MC Larson, AL Feldman, MJ Maurer, AJ Novak, SL Slager, ... American journal of hematology 94 (6), 658-666, 2019 | 25 | 2019 |
| The use of pembrolizumab for the treatment of metastatic uveal melanoma. LA Kottschade, RR McWilliams, S Markovic, MS Block, ... Journal of Clinical Oncology 33 (15_suppl), 9010-9010, 2015 | 23 | 2015 |
| Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT WG Breen, MA Hathcock, JR Young, RO Kowalchuk, R Bansal, ... Journal of hematology & oncology 15 (1), 36, 2022 | 22 | 2022 |
Albert Icksang KoYale School of Public HealthVerified email at yale.edu
